Nurmemmedov Lab

Laboratory of Preclinical Pharmacology of Novel Therapeutics
Principal Investigator: Elmar Nurmemmedov, PhD, MBA

 
 

Nurmemmedov Lab Home

Dr. Nurmemmedov has dedicated much of his scientific career to drug discovery in the field of ‘challenging’ drug targets, particularly transcription factors. At Scintillon Institute, Elmar’s research is focused on preclinical pharmacology of novel therapeutics…

 

Elmar Nurmemmedov,
PhD, MBA